 Immunoregulation onchocerciasis Functional phenotypic abnormalities lymphocyte subsets changes therapy immunoregulatory defects patients onchocerciasis flow cytometric analysis lymphocyte subpopulations parallel functional assays significant differences ratios microfilariae-positive individuals Guatemala Guatemalan controls infected individuals numbers lymphocytes controls Coexpression activation marker HLA-DR cells infected individuals contrast up-regulation HLA-DR cells year initiation treatment semiannual doses microfilaricide ivermectin significant increases percentage cells percentage cells mitogen-induced lymphokine production changes parasite-specific production undetectable treatment follow-up Defects T-cell activation pathway Onchocerca volvulus-infected individuals several independent points state parasite antigen-specific tolerance relative reversal generalized immunoregulatory defects